Bionaut Labs and Candel Therapeutics have teamed up for a fantastic voyage. The newly minted partners plan to use Bionaut’s remote-controlled robots to deliver novel oncolytic viral immunotherapies to brain tumors.

Los Angeles-based Bionaut broke cover earlier this year, emerging from stealth with $20 million to work on microscale robots capable of getting therapeutic payloads to targeted areas of the brain. The idea is to use magnetic fields to guide the robots, which resemble miniature screws, through the body and to sites in the brain to enable the local delivery of biologics, small molecules or other payloads.

Read more here.